Study Evaluating Safety of BT01001 Ophthalmic Solution

NCT07313722 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: BT01001 5 mg/ml（0.5%）
DRUG: BT01001 10 mg/ml（1.0%）
DRUG: BT01001 15 mg/ml（1.5%）
DRUG: Placebo

Sponsor

Beyang Therapeutics Co., Ltd.